PeptideDB

IDH889 1429179-07-6

IDH889 1429179-07-6

CAS No.: 1429179-07-6

IDH889 is an orally bioavailable, brain-penetrating, allosteric and mutation-specific inhibitor of isocitrate dehydrogen
Data collection:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

IDH889 is an orally bioavailable, brain-penetrating, allosteric and mutation-specific inhibitor of isocitrate dehydrogenase (IDH1). IDH889 has high selectivity for IDH1 R132* mutant, with IC50s of 0.02 μM, 0.072 μM and 1.38 μM for IDH1R132H, IDH1R132C and IDH1wt respectively. IDH889 has a potent inhibitory activity against intracellular 2-HG levels, with IC50 of 0.014 μM.

Physicochemical Properties


Molecular Formula C23H25FN6O2
Molecular Weight 436.482007741928
Exact Mass 436.202
CAS # 1429179-07-6
Related CAS # (1R)-IDH889;1429179-08-7
PubChem CID 71542286
Appearance White to off-white solid powder
LogP 4.1
Hydrogen Bond Donor Count 1
Hydrogen Bond Acceptor Count 8
Rotatable Bond Count 6
Heavy Atom Count 32
Complexity 632
Defined Atom Stereocenter Count 2
SMILES

FC1C=CC(=CC=1C)C1C=NC([C@H](C)NC2=NC=CC(=N2)N2C(=O)OC[C@@H]2C(C)C)=NC=1

InChi Key JDCYIMQAIKEACU-HNAYVOBHSA-N
InChi Code

InChI=1S/C23H25FN6O2/c1-13(2)19-12-32-23(31)30(19)20-7-8-25-22(29-20)28-15(4)21-26-10-17(11-27-21)16-5-6-18(24)14(3)9-16/h5-11,13,15,19H,12H2,1-4H3,(H,25,28,29)/t15-,19+/m0/s1
Chemical Name

(4S)-3-[2-[[(1S)-1-[5-(4-fluoro-3-methylphenyl)pyrimidin-2-yl]ethyl]amino]pyrimidin-4-yl]-4-propan-2-yl-1,3-oxazolidin-2-one
Synonyms

IDH 889; IDH-889; IDH889
HS Tariff Code 2934.99.9001
Storage

Powder-20°C 3 years

4°C 2 years

In solvent -80°C 6 months

-20°C 1 month

Shipping Condition Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)

Biological Activity


References

[1]. Optimization of 3-Pyrimidin-4-yl-oxazolidin-2-ones as Allosteric and Mutant Specific Inhibitors of IDH1. ACS Med Chem Lett. 2016 Dec 16;8(2):151-156.


Solubility Data


Solubility (In Vitro) DMSO : ~200 mg/mL (~458.21 mM)
Solubility (In Vivo) Solubility in Formulation 1: 5 mg/mL (11.46 mM) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), suspension solution; with sonication.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL.
Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution.

Solubility in Formulation 2: ≥ 5 mg/mL (11.46 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 50.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.2911 mL 11.4553 mL 22.9106 mL
5 mM 0.4582 mL 2.2911 mL 4.5821 mL
10 mM 0.2291 mL 1.1455 mL 2.2911 mL
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.